Proteogenomic analysis identifies neoantigens and bacterial peptides as immunotherapy targets in colorectal cancer
Considerable progress has recently been made in cancer immunotherapy, including immune checkpoint blockade, cancer vaccine, and adoptive T cell methods. The lack of effective targets is a major cause of the low immunotherapy response rate in colorectal cancer (CRC). Here, we used a proteogenomic str...
Saved in:
Main Authors: | Pengju Yao (Author), Mingjie Gao (Author), Weiyi Hu (Author), Jiahao Wang (Author), Yuhao Wang (Author), Qingsong Wang (Author), Jianguo Ji (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection
by: Yuyu Li, et al.
Published: (2020) -
Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021) -
The Value of Microbes in Cancer Neoantigen Immunotherapy
by: Junrui Tian, et al.
Published: (2023) -
Serodiagnostic antigens of Clonorchis sinensis identified and evaluated by high-throughput proteogenomics.
by: Pyo Yun Cho, et al.
Published: (2020) -
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
by: Zhi Pang, et al.
Published: (2023)